Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center
Open Access
- 1 June 2019
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (6) , e199-e203
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adult T Cell Leukemia-Lymphoma (ATL): State of the ArtCurrent Hematologic Malignancy Reports, 2018
- Epidemiology, clinical features, and outcome of HTLV-1–related ATLL in an area of prevalence in the United StatesBlood Advances, 2018
- Treatment advances and prognosis for patients with adult T-cell leukemia-lymphomaJournal of Clinical and Experimental Hematopathology, 2017
- Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?Bone Marrow Transplantation, 2016
- Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapyOncotarget, 2016
- Treatment and survival among 1594 patients with ATLBlood, 2015
- A Retrospective Analysis of Treatment Outcomes in Adult T Cell Leukemia/Lymphoma Patients with Aggressive Disease Treated with or without Allogeneic Stem Cell Transplantation: A Single-Center ExperienceTransplantation and Cellular Therapy, 2015
- Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphomaThe Lancet Oncology, 2014
- Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective studyBlood, 2010
- Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphomaBritish Journal of Haematology, 1991